Recent studies have identified various molecules for both therapeutic targets and prognostic predictors in gliomas, including RGS16, NLR, TMEM7, SLAMF8, LINC00152, and NUSAP1.27, 28, 29, 30, 31, 32, 33. The gene discussed is CYTOR; the disease is central nervous system cancer.